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Purpose: To evaluate patient satisfaction in Japan and factors, including timing factors, cost, and
speciﬁc medical practices derived from Western inﬂuence (shared decision-making and second
opinion), which might affect satisfaction.
Methods and materials: All patients who presented to 1 large Japanese department of radiation
oncology for postoperative radiation therapy for breast cancer from September 2010 to
November 2013 were included in this study. The questionnaire was distributed to patients after
the radiation oncologist consultation, and patients were asked to complete it anonymously by
the end of treatment. We measured patient satisfaction with overall treatment and for each
treatment separately (surgery, radiation oncology). We further inquired regarding facts that
could affect satisfaction, including time from diagnosis to treatment start, waiting time in
waiting room for consultation, average length of consultations, out-of-pocket cost for breast
cancer treatment, patients’ opinion of the cost, level of inclusion of the patient in decision-
making, level of the patient sharing her feelings with her physician, and whether the patients
had asked for second opinion.
Results: Of 364 patients surveyed, 214 (58.5%) responded. Overall satisfaction and
satisfaction with surgeon and with radiation oncologist were 95.7%, 98.5%, and 98.2%,
respectively. Factors correlated with satisfaction were waiting time for the consult in the
waiting room, treatment cost, and perceived degree of sharing feelings with
physicians. Overall, 27 patients (12.6%) reported having asked for second opinions. Of those
who did not seek a second opinion, most (173) indicated that they did not think it was
necessary.
Conclusions: In a large, typical Japanese radiation oncology practice, breast cancer patients’
satisfaction correlated with waiting time, cost, and the rate with which the patient shared herConﬂicts of interest: None.
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anese system and provides interesting cross-cultural comparative data for other countries in
which the context of care may differ.
Copyright ª 2016 the Authors. Published by Elsevier Inc. on behalf of the American Society
for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Japan is a country with excellent health status, with the
longest life expectancy and one of the lowest rates of
infant mortality.1 In addition, the health care system has 4
potentially advantageous features. First, the universal
health care system ensures that all residents of Japan are
covered regardless of the medical problems they may
have. Second, the system protects patients’ freedom to
choose their health care providers. The patients can go to
any physician they want to see or any clinic or hospital
where they wish to be treated. Third, the low patient
copay required ensures that out-of-pocket expenditure for
health per capita is less than half of that of the United
States.1 Fourth, there is a short waiting time for a doctor
or nurse appointment, including a specialist appointment.
The Organisation for Economic Cooperation and Devel-
opment (OECD) reports reveal that all patients in Japan
can see a doctor or nurse the same or next day when sick
or need care, and all experience waiting times of less than
4 weeks to get a specialist appointment.2 By comparison,
in the United States, only 48% can see a doctor or nurse
the same or next day, and the OECD average proportion
of the population who can do so is 58%. In the United
States, 76% experience waiting times of less than 4 weeks
for specialist appointments, with the OECD average being
58% and 60%.2 Thus, Japan compares quite favorably,
and the expectations of Japanese patients are quite high.
It may sound from the foregoing description as though
Japan has the ideal medical system; however, patient
satisfaction scores in Japan are low compared with other
countries in international studies.3-7 One of the reasons
may be the long waiting time in the waiting room in the
hospital. The aforementioned easy access to hospital care
for patients increases the number of patient visits to the
hospital; the number of doctors’ consultations per capita
is more than 3-fold higher than in the United States.1 This
has, unfortunately, resulted in the notorious Japanese “3
hours wait and 3 minutes consultation.”8 Also, the simple
fact that patients can meet a physician right away does not
mean that they also receive treatment right away. The
diagnosis to treatment time can be affected because of
congestion. Further complicating the situation is that
Japan has directly imported from Western countries
several practices such as documentation of informedconsent, shared decision-making, and solicitation of sec-
ond opinions, without tailoring these to Japanese culture.
The aim of the present study is to describe patient
satisfaction with radiation oncology care in Japan and the
factors, including timing factors (diagnosis to treatment
time, waiting time in the waiting room, and consultation
time), cost, and imported medical practices (shared
decision-making and second opinions), that might affect
patient satisfaction.
Methods and materials
Study sample
Our study sample was all women, diagnosed with breast
cancer, who underwent surgery (mastectomy or breast-
conserving surgery) and who presented to our institution’s
radiation oncology clinic for postoperative radiation
therapy. Our institution, Juntendo Urayasu Hospital, is a
university hospital and is also a “regional core” hospital,
which attracts patients from wide areas. Urayasu is a suburb
of Tokyo with 165,000 residents; because the area contains
the Tokyo Disney Resort, it attracts many people from not
only other cities of Japan, but also from outside of the
country; its predominant local economy is based on tourism.
We included stage 0 to III breast cancer patients who
presented from September 2010 to November 2013. In-
clusion criteria were as follows: breast cancer patients
who came to our department for postoperative radiation
therapy, breast cancer stages 0 to III, age 18 years,
Karnofsky performance status 50, adequate under-
standing of Japanese language, and physical and mental
capability to understand and complete the questionnaires.
Data collection
After institutional review board approval, all eligible
patients were given the study questionnaire after the ra-
diation oncologist consult in the department of radiation
oncology and asked to complete the survey anonymously
before the end of the radiation therapy period, which
lasted between 4 to 6 weeks. The questions in the ques-
tionnaire were all written in Japanese. Study staff was
available for assistance if requested.
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We measured patient satisfaction regarding breast
cancer treatment by using a continuous percentage (full
satisfaction Z 100%; no satisfaction Z 0%) for the
overall treatment and for each speciﬁc treatment (surgery,
radiation therapy). In addition, we asked questions
regarding the following hypothesized correlates of satis-
faction: time from diagnosis to treatment start, waiting
time in the waiting room for consultation, average length
of consultations, out-of-pocket cost for breast cancer
treatment the patient received before start of radiation
therapy (the cost of surgery and, in some patients, sys-
temic therapy), the patients’ opinion of the cost (catego-
rized as “Far too inexpensive,” “Kind of inexpensive,”
“Suitable,” “Kind of expensive,” and “Far too expen-
sive”), the level of inclusion of the patient in decision-
making, the level of patient sharing her feelings with her
physician, and whether the patients had sought second
opinion (when the answer was “No,” the reason for this).
Analytic approach
All statistical analyses were computed using SAS,
version JMP 9.0.0, software (Cary, NC). The correlation
between patient satisfaction and each parameter was
examined with linear regression analysis, using Pearson’s
correlation coefﬁcient. A P value .05 was interpreted asTable 1 Japanese patients’ perceptions and experiences with brea
Mean SD
Patient-reported satisfaction with providers
Overall (n Z 212) 93.02 11.16
Surgeon (n Z 211) 94.75 12.8
Radiation oncologist
(n Z 211)
96.68 7.81
Timing
Minutes of waiting time
(n Z 204)
54.64 41.39
Minutes of consultation
time (n Z 207)
11.4 9.04
Weeks from diagnosis to
treatment (n Z 207)
6.07 3.29
Treatment cost in yen
(n Z 193)a
551,582 729,147
Perceived amount of
involvement in decision
(n Z 214)
42.83 24.35
Perceived degree of
sharing feelings with
physicians (n Z 212)b
92.61 12.79
a In 2013-2014, when this survey was administered, the yen was trading
b Speciﬁcally, patients were asked, “Are you sharing all your opinion (eve
to 100.evidence that the observed difference was statistically
signiﬁcant.Results
Of 366 breast cancer patients surveyed, 2 were
excluded because they had severe dementia and were
considered not to have enough physical and mental
capability to understand and complete the questionnaire,
and 214 (58.5% of the 364 eligible) patients completed
the survey.
Responding patients’ perceptions and experiences with
breast cancer care are summarized in Table 1. Patient
satisfaction with providers was high (>95). Waiting time
was just under an hour for an average 11-minute
consultation, and waiting time was signiﬁcantly nega-
tively associated with overall satisfaction and satisfaction
with the radiation oncologist. Costs for treatments before
radiation therapy were signiﬁcantly negatively associated
with overall satisfaction and satisfaction with radiation
oncologist. Few patients indicated that they perceived cost
to be “far too expensive” (12; 5.7%), but many indicated
that it was “kind of expensive” (102; 48.8%); most others
indicated it was “suitable” (86; 41.2%) with only 9 (4.3%)
suggesting it was “kind of inexpensive” and none
endorsing that it was “far too inexpensive.” Perceptions of
cost were associated with actual reported costs (PZ .05).st cancer care
Correlation with satisfaction with.
Overall Surgeon Radiation oncologist
P Z .01 P Z .46 P Z .03
P Z .5 P Z .29 P Z .63
P Z .72 P Z 39 P Z .18
P Z 02 P Z 26 P < .01
P Z 25 P Z 32 P Z 74
P < .01 P < .01 P < .01
at approximately 100 yen to the US dollar.
n a negative one) with your physician?” and asked to rate on a scale of 1
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was not correlated with satisfaction, but the perceived
degree of sharing feelings with the physician was strongly
associated with satisfaction.
Overall, 27 patients (12.6%) reported having asked for
a second opinion. Those who asked for a second opinion
had a trend toward lower overall satisfaction (P Z .09).
Of those who did not seek a second opinion, most (164)
indicated that they did not think it was necessary (trend to
higher overall satisfaction and satisfaction with radiation
oncologist; P Z .1 and P Z .06, respectively); 19 indi-
cated they wanted to start treatment as soon as possible
(signiﬁcant correlation with lower satisfaction with sur-
geon and trend with low satisfaction with radiation
oncologist; P Z .02 and P Z .1, respectively); 14 indi-
cated that their physician did not explain the option of a
second opinion (signiﬁcant correlation with lower satis-
faction to radiation oncologist; P Z .01); and only 3
worried that seeking a second opinion would make the
physician feel bad (signiﬁcant correlation with lower
overall satisfaction and satisfaction with surgeon; both
P > .01).Discussion
Japan has excellent health outcomes and access to
medical care, but many studies have noted the relatively
low satisfaction of Japanese patients.3-7 We hypothesized
that some of this dissatisfaction related to timing factors
(long waiting time in the waiting room, short consultation
time, and long diagnosis to treatment time), cost, and
speciﬁc medical practices derived from the West (shared
decision-making and second opinion) without tailoring to
Japanese culture. We found that timing factors did indeed
correlate with satisfaction, but satisfaction in this study
was high overall, even though waiting times were high
and consultation times were extremely short.
Given easy access, many patients in Japan go directly
to specialists for care, often favoring those at large aca-
demic institutions. This has led to bankruptcy of small
clinics, because, given the tight proﬁt margin in Japanese
health care, unpopular clinics cannot last long.9 In 1900,
the number of hospitals with beds in Japan used to be
more than 20,000, but is now only 8493.10
The Japanese Ministry of Health, Labor and Welfare
worked out a countermeasure for this situation, deciding
to charge patients an additional fee for direct consultations
with a specialist. In 1994, hospitals with more than 200
beds were advised to charge this fee; from April 2016,
this has been mandatory.10 The amount used to be freely
decided by the hospitals. In a survey done at 2010, 20.2%
were still free of charge, and most of the hospitals set it to
around 1000 yen (the yen was trading at approximately 90
yen to the US dollar in 2010); only 12% of hospitals
required more than 5000 yen, and the most expensive24 hospitals charged 8400 yen.11 From April 2016 on-
ward, a new rule was launched, by which hospitals with
more than 500 beds must charge 5000 yen or more to
patients who come directly to the hospital. Nevertheless,
it remains the case that in many hospitals, including our
institution, there is no need to make a reservation for ﬁrst
visit. Anybody can walk in to the hospital and if paying
the additional fee, can see a specialist on the day they
want.
This necessarily causes waiting times in the Japanese
system. For example, our chief breast cancer surgeon sees
60 to 70 patients a day on average and our radiation
oncologist treat 500 to 600 patients a year in a setting
without resident or trainee support. Moreover, our hos-
pital is not special; this is typical of Japanese university
hospitals. Patients on treatment, re-examination, or
follow-up do have scheduled appointments, but because
the numbers are large, it is almost impossible to see the
patients on time and also to devote meaningful time to
consultations. This causes the notorious situation of a “3
hours wait and 3 minutes consultation.”8 In fact, the
average waiting time was 55 minutes and the average
consultation time was 11 minutes in our study, consid-
erably longer than the consultation time in another Japa-
nese study of only 6 minutes.8 The difference may be
caused by, in that study, patients being general patients; in
our study, however, the patients were all cancer patients.
We expect that an international audience will appreciate
that even 11 minutes is an exceptionally short duration for
a consultation visit with a specialist in radiation oncology.
We also suspect that the international audience will ﬁnd
our waiting times to be long. A study from Stockholm
investigated the waiting times in the waiting room and
consultation time of breast cancer patients.12 Only 3% of
patients waited for 45 to 60 minutes, and most of the
patients’ (55%) consultation times were 5 to 15 minutes.
We observed a signiﬁcant correlation between waiting
time and satisfaction in our study, but no correlation be-
tween consultation time and satisfaction. There are few
studies that investigate the correlation between waiting
time and cancer patients’ satisfaction. Famiglietti and
colleagues from the MD Anderson Cancer Center sur-
veyed 8069 cancer patients who had undergone radiation
therapy and showed that waiting time was 1 of the items
with strong correlation with satisfaction.13 However, in a
systematic review from Denmark, which analyzed 11
studies, waiting time was 1 of 4 dimensions that were not
highly important.14
Another important point is that easy access to imme-
diate physician consultation does not necessarily translate
into immediate commencement of treatment. In our study,
the diagnosis to the ﬁrst treatment time was 6.07 weeks. In
Quebec, the median time from diagnosis to ﬁrst treatment
was 34 days,15 and increased with the number of diag-
nostic procedures performed. The median diagnosis to ﬁrst
treatment time was 48 days with 3 diagnostic procedures,
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3 or 4 diagnostic procedures (ultrasound, mammography,
magnetic resonance imaging, and/or computed tomogra-
phy), which is the case in our institution, where the median
waiting time was 42 days (6.07 weeks). Liederbach and
colleagues16 showed the diagnosis to surgery time of US
breast cancer patients based on the National Cancer Data
Base. The factor that showed correlation with longer than
30 days’ delay was as follows: increasing age, black or
Hispanic race, Medicaid or no insurance, low-education
communities and metropolitan areas, increasing comor-
bidities, stage 0 and grade 1 disease, academic/research
facilities, high-volume facilities, and facilities located in
the New England, Mid-Atlantic, and Paciﬁc regions. Our
institution is an academic, high-volume facility, which is
located in the metropolitan area of Urayasu. This could be
1 reason for our institution’s diagnosis to treatment time
being quite long. Petersen and colleagues14 showed that
diagnosis to ﬁrst treatment time has correlation with pa-
tients’ satisfaction.
In our study, treatment expense had a correlation with
patients’ satisfaction. In Japan, patients younger than 70
years face a 30% copay for medical procedures, whereas
those age 70 years or older have copays ranging from
10% to 30% depending on income; if the monthly copay
reaches a given amount (this depends on the income of
the patient, which ranges from 20,000 to 150,000 yen),
the rest will be reimbursed. The median out-of-pocket
cost of surgery  systemic therapy reported in our study
was 517,850 yen. This is similar to estimates from the
Japanese breast cancer society,17 which estimated that the
total cost of breast-conserving surgery and sentinel lymph
node biopsy and the 7-day hospital stay would be 750,000
yen. Although we did not measure costs of radiation
therapy in our study, we believe it may be of interest to
the international audience that the total cost of radiation
therapy to the breast (25 fractions), is estimated by the
Japanese breast cancer society17 to range from 470,000 to
700,000 yen. The cost of hormonal therapy for 1 year
would be from 140,000 to 550,000 yen. The cost of
chemotherapy would be from 150,000 to 680,000 yen.
The cost of Herceptin (for 18 times use) would be
2,160,000 yen. Of note, these costs represent the total
costs; copays would be 30% of these amounts. Also, if the
monthly expense exceeds the cap as described previously,
the rest would be reimbursed, which means that if treat-
ment ends within 1 month, copays are substantially
reduced.
Even though costs compare favorably to other coun-
tries, in our study, 54.5% of the patients indicated the cost
as “Far too expensive” or “Kind of expensive.” Here,
what matters is not the surgery, because this treatment
ends within 1 month and so much of the cost, which
exceeds the cap, will be reimbursed. What matters here is
the systemic therapy, and because in Japan the cost of
drugs is high, this matters very much. Of all patientsasked to participate in this study, 230 (62.8%) underwent
some form of systemic therapy before radiation therapy
and 10 (2.7%) used Herceptin before radiation therapy.
The perceived amount of involvement in decision-
making did not show any correlation to satisfaction, but
the amount of sharing feelings showed strong correlation
to satisfaction. Bruera and colleagues reported that 89%
of breast cancer patients of the MD Anderson Cancer
Center wanted to be included in treatment decision-
making.18 Janz and colleagues reported that higher edu-
cation was signiﬁcantly associated with patients’
preferred level of control.19 Keating colleagues reported
that 64% of the patients desired a collaborative role in
decision-making and the patients whose reported actual
role matched their desired role were more satisﬁed with
their treatment.20 We hypothesized that relationships be-
tween shared decision-making and satisfaction might
differ in Japanese culture. Our study showed that patients
who rated their perceived amount of involvement in
decision-making highly did not always rate their satis-
faction highly; however, the rate the patient shared her
feeling with her physician did correlate with satisfaction.
According to the report of the Ministry of Health, Labor
and Welfare’s survey conducted among 152,988 pa-
tients,21 44.5% of outpatients and 49.5% of inpatients felt
they could totally share their feelings or ask their ques-
tions, and 6.3% of the outpatients and 7.2% of the in-
patients could not do that at all in Japan. In Japanese
culture, it remains challenging to share one’s feelings, and
our study suggests that even in our culture, if this were
improved, patients’ satisfaction might increase.
Only 12.6% of responding patients in our study re-
ported having asked for a second opinion, and these pa-
tients had a trend toward lower overall satisfaction. Given
the importance of respect for authority in Japanese cul-
ture, one might have worried that more respondents
would have endorsed a concern about second opinions
making the initial physician feel bad. However, it is
possible that some of the many who perceived no need at
all for a second opinion may have so strongly internalized
this norm of respect for authority that they did not even
contemplate questioning it.Conclusion
Our survey showed that breast cancer patients’ satis-
faction correlated with waiting time, cost, and the rate
with which the patient shared her feelings with her
physician. This survey provides insights regarding the
experiences and satisfactions of patients with breast can-
cer in the context of the Japanese health care system. We
hope that this information is informative to others in
different cultures and health care systems as well as to
those within the Japanese system who seek to increase
patient satisfaction.
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